Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Active not recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 87Carcinoma, Non-Small-Cell Lung 78Multiple Myeloma 72Prostatic Neoplasms 66Neoplasms 47Lymphoma 43Leukemia, Myeloid, Acute 42Melanoma 38Neoplasm Metastasis 37Lymphoma, Non-Hodgkin 33Ovarian Neoplasms 32Lung Neoplasms 32Squamous Cell Carcinoma of Head and Neck 31Hematologic Neoplasms 29Leukemia, Lymphocytic, Chronic, B-Cell 28Colorectal Neoplasms 26Triple Negative Breast Neoplasms 23Hodgkin Disease 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Myelodysplastic Syndromes 21Sarcoma 20Fallopian Tube Neoplasms 20Pancreatic Neoplasms 19Carcinoma, Renal Cell 19Lymphoma, Follicular 17Leukemia 17Head and Neck Neoplasms 17Glioma 17Urinary Bladder Neoplasms 16Recurrence 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Synovitis, Pigmented Villonodular × 90 days × Clear all
NCT05804045 2026-05-04

Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)

Abbisko Therapeutics Co, Ltd

Phase 3 Active not recruiting
94 enrolled 16 charts

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT05059262 2026-03-20

MOTION

Deciphera Pharmaceuticals, LLC

Phase 3 Active not recruiting
123 enrolled 19 charts 1 FDA

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡